Latest filing published 06 Jan 2026 for Cartesian Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Patrick J. Zenner, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cartesian Therapeutics, Inc. and West Pharmaceutical Services Inc. In total, 5 filings cover trades dated from 4 May 2021 to 2 January 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 6 January 2026, reports a share grant in Cartesian Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations